Results 91 to 100 of about 2,707 (157)

A New Era in Tuberculosis Prevention and Treatment: Breakthroughs in Drug Development and Future Prospects. [PDF]

Infect Dis Ther
Zhao CY, Song C, Lu YB, Huang AC, Zeng CM, Liu RH, Li WW, Xie ZH, Zhu QD.   +8 more
europepmc   +1 more source

New drugs for the management of tuberculosis. [PDF]

Curr Opin Infect Dis
Cross GB.
europepmc   +1 more source

Corrigendum to "Model-Informed Once-Daily Dosing Strategy for Bedaquiline and Delamanid in Children, Adolescents and Adults with Tuberculosis". [PDF]

Clin Pharmacol Ther
europepmc   +1 more source

Pre-extensively drug-resistant tuberculosis of the spine in a previously healthy young adult: case report. [PDF]

BMC Infect Dis
Schreurs H, Dejaegher J, Decroo T, André E, Lorent N, Henckaerts L.   +5 more
europepmc   +1 more source

The time is now: making the case for compassionate use/pre-approval access to new TB drugs. [PDF]

IJTLD Open
Reuter A, Stillo J, Thi SS, Motta I, Migliori GB, Mesic A, Mbenga M, Howell P, Guglielmetti L, Gebhard A, DeCroo T, D'Ambrosio L, Furin J.   +12 more
europepmc   +1 more source

Rifampicin-resistant tuberculosis in Spain. [PDF]

ERJ Open Res
García-García JM, Rodrigo-Sanz T, Gullón-Blanco JA, Casas García X, Millet JP, Quirós Fernández S, Martínez Lirola MJ, Mangas Moro A, Domínguez Castellano Á, Navas Elorza E, Nieto Marcos M, Arasa Panisello F, Bermúdez Ruiz P, García Cabrera M, Sanz Herrero F, Suárez Toste I, Urrelo Cerrón LA, Espiau Guarner M, Soriano Arandes A, Arias Guillén M, Cebrián Gallardo JJ, García-Fuertes JA, Pérez-Jacoiste Asín MA, Somoza González M, Palacios Gutiérrez JJ, Alcaide F, Samper Blasco S, Tabernero Huguet E, Caylà JA, Ruiz Manzano J, Caminero Luna JA, Working Group on Rifampicin Resistant Tuberculosis of the Tuberculosis Research Programme (PII-TB) SEPAR .   +31 more
europepmc   +1 more source

Whole genome sequencing-based detection of extensively drug-resistant tuberculosis from Ethiopia. [PDF]

Commun Med (Lond)
Diriba G, Mollalign H, Meaza A, Getu M, Zerihun B, Alemu A, Dagne B, Abebaw Y, Weldemariam AG, Bashea C, Ali A, Seid G, Getahun M, Hailu M, Wondimu A, Getachew T, Kumsa A, Letta T, Liaulseged A, Abera NA, Abate Z, Alemu E, Challa F, Tadesse G, Abdella S, Tollera G, Dangisso MH.   +26 more
europepmc   +1 more source

Novel Pharmacological Approaches for Multidrug-Resistant Tuberculosis: Review. [PDF]

Adv Pharmacol Pharm Sci
Ayenew KD, Habteweld HA, Tsige AW, Bizu YS.   +3 more
europepmc   +1 more source

Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice. [PDF]

J Infect Dis
Lee BY, Clemens DL, Masleša-Galic S, Nava S, Lo CY, Zink JI, Horwitz MA.   +6 more
europepmc   +1 more source

Development of machine learning models to identify potentially active compounds against tuberculosis. [PDF]

Sci Rep
Rawat A, Gupta S, Pal C, Chowdhury S.
europepmc   +1 more source